RE:RE:RE:RE:RE:Media section/ covid Immunity Passport Page - So initial announcement was around March 2020 and now Said expected revenue in q3 /q4 2020. - without any shame they went on to say expected revenues will be in q4 2021, so technically we have to wait until they announce q4 in March 2022. Never thought of clarifying this to investors about why the delay. - rc has stated b4 that the lack of pr might due to pending regulatory approvals , but what the heck are they going to commercialize to begin with ? - I understand serology is not their priority but shows overall how much we can rely on this management. - stuck here coz of fomo